Mitesh

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 11 June 2024) has been published and includes articles on: Topiramate (Topamax®): introduction of new safety measures, including a Pregnancy Prevention Programme Warfarin: be alert to the risk of drug interactions with tramadol Letters and medicine recalls sent to healthcare [...]

The post MHRA Drug Safety Update: June 2024 appeared first on Community Pharmacy England.

Class 3 Medicines Recall: GoResp Digihaler (Teva UK Ltd) Drug alert number: EL (24)A/23 Date issued: 18 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for GoResp Digihaler (Teva UK Ltd). Company name: Teva UK Ltd Product name: GoResp Digihaler, PLGB 00289/2501 SNOMED Code: 42007211000001108 Batch Number [...]

The post MHRA Class 3 Medicines Recall: GoResp Digihaler (Teva UK Ltd) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomil® XL 60mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP059 Monomil® XL 60mg tablets expires at 23.59pm on Friday 7 June 2024. After this date, any prescriptions for Monomil® XL 60mg [...]

The post Expiry of SSP059 Monomil® XL 60mg tablets appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/20 Date issued: 06 June 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Lamotrigine Desitin 10mg/ml oral suspension (Desitin Pharma UK Ltd) PL 14040/0040 SNOMED Code: 42751111000001102 Batch No Expiry Date Pack Size First Distributed 024171A1 31/01/2026 300ml 07-May-24 024172A1 31/01/2026 300ml [...]

The post MHRA Class 2 Medicines Recall: Lamotrigine Desitin 10mg/ml oral suspension (Desitin Pharma UK Ltd) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions Letters and medicine recalls sent to healthcare professionals in [...]

The post MHRA Drug Safety Update: May 2024 appeared first on Community Pharmacy England.